$96.87
0.220.23%
Last update: Oct 30, 5:16 PM
Oruka Therapeutics Inc (ORKA) Stock Price, Quote, News & History
ORKANASDAQ
Oruka Therapeutics reported positive Week 16 Phase 2b data for ORKA-001, showing 61% complete skin clearance in plaque psoriasis patients.
You can purchase shares of Oruka Therapeutics (NASDAQ:ORKA) through any online brokerage.
Other companies in Oruka Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Oruka Therapeutics has a consensus price target of $87.06.
The stock price for Oruka Therapeutics (NASDAQ: ORKA) is $96.5 last updated October 30, 2026 at 5:16 PM EDT.
There are no upcoming dividends for Oruka Therapeutics.
Oruka Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Oruka Therapeutics.
Oruka Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its programs are to treat and potentially...
